Bio Developments

GE rolls out 'off the shelf' MAb factories

GE launches range of 'off the shelf' MAb facilities

By Gareth Macdonald

GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.

M&A, partnerships and new services in pharma outsourcing

New pharma services from M&A and partnerships: round-up

By Natalie Morrison

Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and Accenture’s new...

GE and iBio designing plant-cell based vaccine facility

GE and iBio designing plant-cell based vaccine facility

By Gareth Macdonald

GE Healthcare has started designing a vaccine manufacturing facility for an unnamed drug company, just days after expanding its collaboration with plant-cell production technology firm iBio.

Fog, yesterday

Linde says cryogenic fog can help freeze-dry biologics

By Gareth Macdonald

Industrial gas supplier Linde claims its 'cryogenic fog' technology is the first commercially-feasible way of controlling ice-crystal formation during the lyophilisation of biologic drugs.

Illustration of the nanolipogel administering its immunotherapy cargo.

Nanoshells could solve oncology dual delivery riddle

By Natalie Morrison

Hollow nano shells capable of holding both cancer fighting drugs and immune-system boosters could be the solution to oncology’s greatest delivery riddle, according to Yale University researchers.

FDA publishes Celltex Therapeutics inspection 483

FDA publishes Celltex Therapeutics inspection 483

By Gareth Macdonald

The US FDA has published a 483 detailing the violations it observed during an inspection of stem cell firm Celltex Therapeutics in April and the document does not make for comfortable reading.